Knee Replacement Systems for Osteoarthritis

N/A

Recruiting

Led By James Nace, MD

Research Sponsored by LifeBridge Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subject is male or non-pregnant female aged between 18 and 75 years of age.

Subject is male or non-pregnant female aged between 18 and 75 years of age

Must not have

Subject has a diagnosis of avascular necrosis or inflammatory arthritis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre-operative; post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit

Awards & highlights

No Placebo-Only Group

Summary

This trial is comparing two types of knee replacements to see which works better for patients with degenerative joint disease.

Who is the study for?

This trial is for men and non-pregnant women aged 18-75 who need a knee replacement due to degenerative joint disease. They must be able to walk, attend follow-up visits, and not have had previous knee replacements or conditions that would affect walking tests.

What is being tested?

The study compares two types of knee implants: the MicroPort Evolution Medial-Pivot Knee System and the Stryker Triathlon Tritanium Knee System. It will assess which design better improves pain relief, function, and patient satisfaction after surgery.

What are the potential side effects?

Potential side effects from total knee replacement may include pain at the surgery site, swelling, stiffness in the knee joint, infection risk at the wound site or within the new joint.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a man or a non-pregnant woman aged 18 to 75.

Select...

I am a man or a non-pregnant woman aged 18 to 75.

Select...

I am approved for a total knee replacement using specific knee implants.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with avascular necrosis or inflammatory arthritis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ operative visit; post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~operative visit; post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and operative visit; post-operative - 6 week, 6 month, 12 month, 24 month, 36 month, and 60 month follow-up visit for reporting.